Guaifenesin And Pseudoephedrine Hcl Tablet, Extended Release
Product Images NDC 55111-799

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Pseudoephedrine Hcl (NDC 55111-799). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddys Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Guaifenesin 600 mg and Pseudoephedrine HCl 60 mg Extended-Release Tablets by Dr. Reddy's Laboratories Limited. The box contains 9 extended-release tablets. The label highlights the product as an expectorant and nasal decongestant with 12-hour extended release, and mentions its benefits for clearing nasal/sinus congestion and thinning and loosening mucus. The NDC number 55111-798-09 is displayed on the front.*

FDA Label Image

Carton18 (Carton18)

Packaging label for Guaifenesin 600 mg and Pseudoephedrine HCl 60 mg Extended-Release Tablets by Dr. Reddy's Laboratories Limited. The carton contains 18 extended-release tablets and highlights uses as an expectorant and nasal decongestant. The label includes drug facts, warnings, and active ingredients with a depiction of a 12-hour release time.*

FDA Label Image

Carton2 (Carton2)

Packaging label for Guaifenesin 1200 mg and Pseudoephedrine HCl 120 mg extended-release tablets by Dr. Reddy's Laboratories. The carton contains 12 extended-release tablets and highlights its use as an expectorant and nasal decongestant. The label includes dosage strength, quantity, and a 12-hour effectiveness icon.*

FDA Label Image

Carton3 (Carton3)

Flat packaging label for Guaifenesin 1200 mg and Pseudoephedrine HCl 120 mg Extended-Release Tablets by Dr. Reddy's Laboratories Limited. The label highlights the product as an expectorant and nasal decongestant, with 24 extended-release tablets per carton. It includes dosage strength, a barcode, NDC number 55111-799-04, and manufacturer details from India. The label also features Drug Facts sections detailing uses, warnings, directions, and inactive ingredients.*

FDA Label Image

Carton36 (Carton36)

Packaging label for Guaifenesin 600 mg and Pseudoephedrine HCl 60 mg Extended-Release Tablets by Dr. Reddy's Laboratories Limited. The label indicates 36 extended-release tablets, marketed as an expectorant and nasal decongestant. It features dosing and usage information along with warnings, ingredients, drug facts, and the product's NDC 55111-798-41.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.